PELP1 oncogenic functions involve alternative splicing via PRMT6 - Wikidata - awgldk - TriplyDB

PELP1 oncogenic functions involve alternative splicing via PRMT6

PELP1 oncogenic functions involve alternative splicing via PRMT6

http://www.wikidata.org/entity/Q28306263

about

Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma Proline-, glutamic acid-, and leucine-rich protein 1 mediates estrogen rapid signaling and neuroprotection in the brain Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer PELP1: Structure, biological function and clinical significance.Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.Deregulation of splicing factors and breast cancer development.Histone Modifications and Cancer.The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer.

P2860

Q28239216-A7F27E80-1201-4A45-BA4B-43A14275B6B9 Q28251097-B818E272-3D0B-4112-B015-AE143EF12162 Q34503754-0A053E93-82E9-447F-8ECB-3C3F50D7EE22 Q35738599-E90D8633-AF62-4F7C-ABC7-DBEE80952C96 Q36818434-ED245D17-1A3C-4B7E-A2B9-782CEA831D7D Q37708863-725E0727-9FAB-4F0C-8605-9658DB2D7B8C Q38463397-D2C6A57A-F84A-4EDD-8620-A3807FAA47C6 Q38796064-608E67FD-E4A9-4566-A0A1-58F221E1DB54 Q47138155-37D9677F-7074-4DA8-B316-0ABAACCB13AE

P2860

PELP1 oncogenic functions involve alternative splicing via PRMT6

http://www.wikidata.org/entity/Q28306263

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

PELP1 oncogenic functions involve alternative splicing via PRMT6

@ast

PELP1 oncogenic functions involve alternative splicing via PRMT6

@en

PELP1 oncogenic functions involve alternative splicing via PRMT6

@nl

type

label

PELP1 oncogenic functions involve alternative splicing via PRMT6

@ast

PELP1 oncogenic functions involve alternative splicing via PRMT6

@en

PELP1 oncogenic functions involve alternative splicing via PRMT6

@nl

prefLabel

PELP1 oncogenic functions involve alternative splicing via PRMT6

@ast

PELP1 oncogenic functions involve alternative splicing via PRMT6

@en

PELP1 oncogenic functions involve alternative splicing via PRMT6

@nl

P1433

Q28306263-6642347C-086A-4081-8C82-40D04319C64E

P1476

Q28306263-7974312E-E877-419C-83FB-76D0B5D2969A

P2093

Q28306263-3BA5A306-4884-48CD-A7D8-DE1FD75E7B78

Q28306263-4B5A2F96-435F-4A02-B086-BB93AF87ECAE

Q28306263-749FFE84-1D90-4B13-8522-D62BE97D656F

Q28306263-7822153D-C9AD-472A-A240-7C61A3508951

Q28306263-FFD0D992-6E1B-4E06-BAB6-A24A7B46FB1C

P2860

Q28306263-18583BE7-3F7D-4F00-AD6F-830BACD2F661

Q28306263-1D00EF59-F79E-432A-B473-BFFA311FEA75

Q28306263-1E296BAA-3EDE-4817-93C0-2D8B19D0AB3B

Q28306263-367F5425-3EEA-4293-9DEE-D534ED2791D5

Q28306263-37ACF251-7929-4977-88EE-610BC4B5B6E6

Q28306263-3A360946-6A57-419A-923E-20AD726F4B0E

Q28306263-440BAFDA-A24E-4972-AEEE-08C6210A9243

Q28306263-50BC34DF-07DD-49F8-80F6-0B5ABE00E4B6

Q28306263-510C4C98-58BF-4CF2-AC08-ED9B2822A227

Q28306263-522F3F1B-2D0D-4AC6-B69B-93072C942C9D

P304

Q28306263-E9A4382F-877B-481C-801A-D536F08C4E13

P31

Q28306263-C522E0DC-153F-4D61-B30E-8A4776E7C93F

P356

Q28306263-0A115188-FF24-4A93-B144-535DAE790DA5

P407

Q28306263-86485018-0289-4C6B-B8E5-08FD92254738

P433

Q28306263-D2019EF6-496F-449A-9021-55D0760FECEC

P478

Q28306263-C123D29F-BA88-4921-A8F3-E8E32C59B963

P577

Q28306263-FAE7900E-4D6D-41F7-BC3B-F9E0D062FFB9

P5875

Q28306263-D3CF53B6-5902-4D26-975F-27AE171FB5DA

P698

Q28306263-6E390997-D34D-4612-8B06-9DF7E5841CCC

P921

Q28306263-08A40609-8DC6-4464-AA10-74BD17DA6331

P932

Q28306263-5621E447-AD93-4D06-B0FB-983B8396A48E

P356

J.MOLONC.2013.12.012

P1433

Molecular Oncology

P1476

PELP1 oncogenic functions involve alternative splicing via PRMT6

@en

P2093

Darrell Brann

http://www.w3.org/2001/XMLSchema#string

Monica Mann

http://www.w3.org/2001/XMLSchema#string

Ratna Vadlamudi

http://www.w3.org/2001/XMLSchema#string

Yi Zou

http://www.w3.org/2001/XMLSchema#string

Yidong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression analysis for sequence count data

The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex

An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K

Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1)

PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity

Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a

Arginine methylation of RNA helicase a determines its subcellular localization

Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein

Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1

TopHat: discovering splice junctions with RNA-Seq

P304

389-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2013.12.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259523873

http://www.w3.org/2001/XMLSchema#string

P698

24447537

http://www.w3.org/2001/XMLSchema#string

P921

P932

3943689

http://www.w3.org/2001/XMLSchema#string